HIV/SIV glycoproteins: Structure-function relationships

Journal of Molecular Biology

Volumn 273, Issue 1, 1997, Pages 122-149

  Douglas, N W ^a   Munro, G H ^a   Daniels, R S ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Domain structure; Function; Glycoprotein; HIV SIV; Phenotype

Indexed keywords

CHEMOKINE RECEPTOR; GLYCAN; GLYCOPROTEIN GP 120; MEMBRANE PROTEIN; MUTANT PROTEIN; PROTEIN SUBUNIT; SIGNAL PEPTIDE; VIRUS GLYCOPROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONSENSUS SEQUENCE; DISULFIDE BOND; DRUG DEVELOPMENT; HUMAN IMMUNODEFICIENCY VIRUS; MUTAGENESIS; NONHUMAN; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; RECEPTOR BINDING; SIMIAN VIRUS; VIRUS INFECTIVITY; VIRUS REPLICATION;

EID: 0031576346     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1997.1277     Document Type: Article

References (234)

1. Ahmad N., Baroudy B. M., Baker R. C., Chappey C. Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J. Virol. 69:1995;1001-1012.
2. Alizon M., Wain-Hobson S., Montagnier L., Sonigo P. Genetic variability of the AIDS virus: nucleotide sequence analysis of 2 isolates from African patients. Cell. 46:1986;63-74.
3. Arroyo J., Boceta M., Gonzalez M. E., Michel M., Carrasco L. Membrane permeabilization by different regions of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41. J. Virol. 69:1995;4095-4102.
4. Atchison R. E., Gosling J., Monteclaro F. S., Franci C., Digilio L., Charo I. F., Goldsmith M. A. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science. 274:1996;1924-1926.
5. Bachmann M. H., Delwart E. L., Shpaer E. G., Lingenfelter P., Singal R., Mullins J. I. Rapid genetic characterization of HIV type 1 strains from four World Health Organization-sponsored vaccine evaluation sites using a heteroduplex mobility assay. AIDS Res. Hum. Retrovir. 10:1994;1345-1353.
6. Back N. K., Smit L., De Jong J. J., Keulen W., Schutten M., Goudsmit J., Tersmette M. An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralisation. Virology. 199:1994;431-438.
7. Baier M., Garber C., Muller C., Cichutek K., Kurth R. Complete nucleotide sequence of a simian immunodeficiency virus from African-Green monkeys: a novel type of intragroup divergence. Virology. 176:1990;216-221.
8. Barnett S. W., Quiroga M., Werner A., Dina D., Levy J. A. Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type-2 UC1 strain. J. Virol. 67:1993;1006-1014.
9. Bayer P., Kraft M., Ejchart A., Westendorp M., Frank R., Rosch P. Structural studies of HIV-1 Tat protein. J. Mol. Biol. 247:1995;529-535.
10. Bayon Auboyer M. H., Boussin F. D., Vogt G., Le Grand R., Vaslin B., Nicol Jourdain I., Dormont D. Evolution of the human immunodeficiency virus type 2 envelope gene in preimmunized and persistently infected rhesus macaques. J. Virol. 68:1994;3415-3420.
11. Benjouad A., Gluckman J. C., Montagnier L., Bahraoui E. Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160. J. Virol. 67:1993;1693-1697.
12. Benveniste R. E., Morton W. R., Clark E. A., Tsai C. C., Ochs H. D., Ward J. M., Kuller L., Knott W. B., Hill R. W., Gale M. J., Thouless M. E. Inoculation of baboons and macaques with simian immunodeficiency virus MNE, a primate lentivirus closely related to human immunodeficiency virus type-2. J. Virol. 62:1988;2091-2101.
13. Berman P. W., Nunes W. M., Haffar O. K. Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1in vitro. J. Virol. 62:1988;3135-3142.
14. Bernstein H. B., Compans R. W. Sulfation of the human immunodeficiency virus envelope glycoprotein. J. Virol. 66:1992;6953-6959.
15. Bernstein H. B., Tucker S. P., Hunter E., Schutzbach J. S., Compans R. W. Human immunodeficiency virus type-1 envelope glycoprotein is modified by O-linked oligosaccharides. J. Virol. 68:1994;463-468.
16. Bhat S., Mettus R. V., Reddy E. P., Ugen K. E., Srikanthan V., Williams W. V., Weiner D. B. The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275. AIDS Res. Hum. Retrovir. 9:1993;175-181.
17. Bieniasz P. D., Fridell R. A., Aramori I., Ferguson S. S. G., Caron M. G., Cullen B. R. HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR5 coreceptor. EMBO J. 16:1997;2599-2609.
18. Biti R., French R., Young J., Bennetts B., Stewart G., Liang T. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat. Med. 3:1997;252-253.
19. Bjorling E., Chiodi F., Utter G., Norrby E. Two neutralizing domains in the V3 region in the envelope glycoprotein gp125 of HIV type 2. J. Immunol. 152:1994;1952-1959.
20. Bosch F. X., Orlich M., Giesendorf B., Rott R., Daniels R. S., Skehel J. J. Sequence of the haemagglutinin cleavage site of the pathogenic avian influenza virus A/Fowl/Victoria/75 and of non-pathogenic variants therefrom: minimal requirements for proteolytic cleavability. The Biology of Negative Strand Viruses. 1987;Elsevier, Amsterdam.
21. Bosch M. L., Andeweg A. C., Schipper R., Kenter M. Insertion of N-linked glycosylation sites in the variable regions of the human immunodeficiency virus type 1 surface glycoprotein through AAT triplet reiteration. J. Virol. 68:1994;7566-7569.
22. Botarelli P., Houlden B. A., Haigwood N. L., Servis C., Montagna D., Abrignani S. N-Glycosylation of HIV-gp120 may constrain recognition by T lymphocytes. J. Immunol. 147:1991;3128-3132.
23. Boyd M. T., Simpson G. R., Cann A. J., Johnson M. A., Weiss R. A. A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J. Virol. 67:1993;3649-3652.
24. Brelot A., Heveker N., Pleskoff O., Sol N., Alizon M. Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity. J. Virol. 71:1997;4744-4751.
25. Breuer J., Douglas N. W., Goldman N., Daniels R. S. Human immunodeficiency virus type 2 (HIV-2)env. J. Gen. Virol. 76:1995;333-345.
26. Bugelski P. J., Maleeff B. E., Klinkner A. M., Ventre J., Hart T. K. Ultrastructural evidence of an interaction between env and gag proteins during assembly of HIV type 1. AIDS Res. Hum. Retrovir. 11:1995;55-64.
27. Cao J., Bergeron L., Helseth E., Thali M., Repke H., Sodroski J. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J. Virol. 67:1993;2747-2755.
28. Carrillo A., Ratner L. Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: role of the V3 loop and C4 envelope determinants. J. Virol. 70:1996;1301-1309.
29. Catasti P., Bradbury E. M., Gupta G. Structure and polymorphism of HIV-1 third variable loops. J. Biol. Chem. 271:1996;8236-8242.
30. Chakrabarti L., Guyader M., Alizon M., Daniel M. D., Desrosiers R. C., Tiollais P., Sonigo P. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature. 328:1987;543-547.
31. Chan D. C., Fass D., Berger J. M., Kim P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89:1997;263-273.
32. Chen S. S. Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 68:1994;2002-2010.
33. Chernomordik L., Chanturiya A. N., Suss-Toby E., Nora E., Zimmerberg J. An amphipathic peptide from the COOH-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J. Virol. 68:1994;7115-7123.
34. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P. D., Wu L., Mackay C. R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1996;1135-1148.
35. Cichutek K., Merget H., Norley S., Linde R., Kreuz W., Gahr M., Kurth R. Development of a quasispecies of human immunodeficiency virus type 1in vivo. Proc. Natl Acad. Sci. USA. 89:1992;7365-7369.
36. Clapham P. R., McKnight A., Weiss R. A. Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4. J. Virol. 66:1992;3531-3537.
37. Clavel F., Guyader M., Guetard D., Salle M., Montagnier L., Alizon M. Molecular cloning and polymorphism of the human immune deficiency virus type-2. Nature. 324:1986;691-695.
38. Claverie J., Daulmerie C. Smoothing profiles with sliding windows: better to wear a hat! CABIOS. 7:1991;113-115.
39. Connor R. I., Sheridan K. E., Ceradini D., Choe S., Landau N. R. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185:1997;621-628.
40. Cornelissen M., Hogervorst E., Zorgdrager F., Hartman S., Goudsmit J. Maintenance of syncytium-inducing phenotype of HIV type-1 is associated with positively charged residues in the HIV type-1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites. AIDS Res. Hum. Retrovir. 11:1995;1169-1175.
41. Dash B., McIntosh A., Barrett W., Daniels R. Deletion of a single N-linked glycosylation site from the transmembrane envelope protein of human immunodeficiency virus type 1 stops cleavage and transport of gp160 preventingenv. J. Gen. Virol. 75:1994;1389-1397.
42. Dayhoff M., Eck R. V. A model of evolutionary change in proteins. Dayhoff M., Eck R. V. Atlas of Protein Sequence and Structure. 1968;National Biomedical Research Foundation, Silver Spring.
43. de Jong J. J., Goudsmit J., Keulen W., Klaver B., Krone W., Tersmette M., de Ronde A. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J. Virol. 66:1992;757-765.
44. De Santis C., Lopalco L., Robbioni P., Longhi R., Rappocciolo G., Siccardi A. G., Beretta A. Human antibodies to immunodominant C5 region of HIV-1 gp120 cross-react with HLA class I on activated cells. AIDS Res. Hum. Retrovir. 10:1994;157-162.
45. De Wolf F., Hogervorst E., Goudsmit J., Fenyo E. M., Rubsamen-Waigmann H., Holmes H., Galvao-Castro B., Karita E., Wasi C., Sempala S. D. K., Baan E., Zorgdrager F., Lukashov V., Osmanov S., Kuiken C., Cornelissen M. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. AIDS Res. Hum. Retrovir. 10:1994;1387-1400.
46. Dean M., Carrington M., Winkler C., Huttley G. A., Smith M. W., Allikmets R., Goedert J. J., Buchbinder S. P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., O'Brien S. J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 273:1996;1856-1862.
47. Delahunty M. D., Rhee I., Freed E. O., Bonifacino J. S. Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: identification of critical glycine residues. Virology. 218:1996;94-102.
48. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R. E., Hill C. M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. Identification of a major coreceptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
49. Dewhurst S., Embretson J. E., Anderson D. C., Mullins J. I., Fultz P. N. Sequence analysis and acute pathogenicity of molecularly cloned SIVsmm-PBJ14. Nature. 345:1990;636-640.
50. Ditzel H. J., Parren P. W. H. I., Binley J. M., Sodroski J., Moore J. P., Barbas C. F., Burton D. R. Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries. J. Mol. Biol. 267:1997;684-695.
51. Doe B., Steimer K. S., Walker C. M. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans. Eur. J. Immunol. 24:1994;2369-2376.
52. Doranz B. J., Rucker J., Yi Y., Smyth R. J., Samson M., Peiper S. C., Parmentier M., Collman R. G., Doms R. W. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3 and CKR-2b as fusion cofactors. Cell. 85:1996;1149-1158.
53. Douglas N. W., Knight A. I., Hayhurst A., Barrett W. Y., Kevany M. J., Daniels R. S. An efficient method for the rescue and analysis of functional HIV-1envtatrev. AIDS. 10:1996;39-46.
54. Dragic T., Litwin V., Allaway G. P., Martin S. R., Huang Y. X., Nagashima K. A., Cayanan C., Maddon P. J., Koup R. A., Moore J. P., Paxton W. A. HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
55. Dubay J. W., Roberts S. J., Hahn B. H., Hunter E. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 66:1992;6616-6625.
56. Ebenbichler C. F., Stoiber H., Schneider R., Patsch J. R., Dierich M. P. The human immunodeficiency virus type 1 transmembrane gp41 protein is a calcium-binding protein and interacts with the putative second-receptor molecules in a calcium-dependent manner. J. Virol. 70:1996;1723-1728.
57. Edinger A. L., Amedee A., Miller K., Doranz B. J., Endres M., Sharron M., Samson M., Lu Z.-H., Clements J. E., Murphey-Corb M., Peiper S. C., Parmentier M., Broder C. C., Doms R. W. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc. Natl Acad. Sci. USA. 94:1997;4005-4010.
58. Ellerbrok H., D'Auriol L., Vaquero C., Sitbon M. Functional tolerance of the human immunodeficiency virus type 1 envelope signal peptide to mutations in the amino-terminal and hydrophobic regions. J. Virol. 66:1992;5114-5118.
59. Endres M. J., Clapham P. R., Marsh M., Ahuja M., Turner J. D., McKnight A., Thomas J. F., Stoebenau-Haggarty B., Choe S., Vance P. J., Wells T. N., Power C. A., Sutterwala S. S., Doms R. W., Landau N. R., Hoxie J. A. CD4-independent infection by HIV-2 is mediated by fusin/CXCR-4. Cell. 87:1996;745-756.
60. Eugen-Olsen J., Iversen A. K. N., Garred P., Koppelhus U., Pedersen C., Benfield T. L., Sorenson A. M., Katzenstein T., Dickmeiss E., Gerstoft J., Skinhoj P., Svejgaard A., Nielsen J. O., Hofmann B. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS. 11:1997;305-310.
61. Fantini J., Yahi N., Chermann J. C. Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells. Proc. Natl Acad. Sci. USA. 88:1991;9297-9301.
62. Feng Y., Broder C. C., Kennedy P. E., Berger E. A. HIV-1 entry cofactor: functional cDNA cloning of a 7-transmembrane, G-protein-coupled receptor. Science. 272:1996;872-877.
63. Fenouillet E., Gluckman J. C., Jones I. M. Functions of HIV envelope glycans. Trends Biochem. Sci. 19:1994;65-70.
64. Fenouillet E., Miquelis R., Drillien R. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell-lines. Virology. 218:1996;224-231.
65. Ferzan M., Choe H., Martin K. A., Sun Y., Sidelko M., Mackay C. R., Gerard N. P., Sodroski J., Gerard C. HIV-1 entry and Macrophage Inflammatory Protein-1β-mediated signaling are independent functions of the chemokine receptor CCR5. J. Biol. Chem. 272:1997;6854-6857.
66. Fomsgaard A., Hirsch V. M., Allan J. S., Johnson P. R. A highly divergent proviral DNA clone of SIV from a distinct species of African-Green monkey. Virology. 182:1991;397-402.
67. Fox D. G., Balfe P., Palmer C. P., May J. C., Arnold C., McKeating J. A. Length polymorphism within the second variable region of the Human Immunodeficiency Virus type 1 envelope glycoprotein affects accessibility of the receptor binding site. J. Virol. 71:1997;759-765.
68. Freed E. O., Martin M. A. Domains of the human immunodefiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70:1996;341-351.
69. Fukasawa M., Miura T., Hasegawa A., Morikawa S., Tsujimoto H., Miki K., Kitamura T., Hayami M. Sequence of simian immunodeficiency virus from African-Green monkey, a new member of the HIV/SIV Group. Nature. 333:1988;457-461.
70. Gao F., Yue L., Craig S., Thornton C. L., Robertson D. L., McCutchan F. E., Bradac J. A., Sharp P. M., Hahn B. H. Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. AIDS Res. Hum. Retrovir. 10:1994a;1359-1368.
71. Gao F., Yue L., Robertson D. L., Hill S. C., Hui H., Biggar R. J., Neequaye A. E., Whelan T. M., Ho D. D., Shaw G. M., Sharp P. M., Hahn B. H. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J. Virol. 68:1994b;7433-7447.
72. Gao F., Morrison S. G., Robertson D. L., Thornton C. L., Craig S., Karlsson G., Sodroski J., Morgado M., Galvao-Castro B., von Briesen H., Beddows S., Weber J., Sharp P. M., Shaw G. M., Hahn B. H. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. J. Virol. 70:1996;1651-1657.
73. Gartner S., Markovits P., Markovitz D. M., Kaplan M. H., Gallo R. C., Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science. 233:1986;215-219.
74. Gottlinger H. G., Dorfman T., Cohen E. A., Haseltine W. A. The role of the tnv protein and thetnv. Virology. 189:1992;618-628.
75. Gram G. J., Hemming A., Bolmstedt A., Jansson B., Olofsson S., Akerblom L., Nielsen J. O., Hansen J. E. Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4. Arch. Virol. 139:1994;253-261.
76. Grantham R. Amino acid difference formula to help explain protein evolution. Science. 185:1974;862-864.
77. Grez M., Dietrich U., Balfe P., von Briesen H., Maniar J. K., Mahambre G., Delwart E. L., Mullins J. I., Rubsamen Waigmann H. Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses. J. Virol. 68:1994;2161-2168.
78. Grimaila R. J., Fuller B. A., Rennert P. D., Nelson M. B., Hammarskjold M. L., Potts B., Murray M., Putney S. D., Gray G. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics and neutralization. J. Virol. 66:1992;1875-1883.
79. Haggerty S., Dempsey M. P., Bukrinsky M. I., Guo L., Stevenson M. Post-translational modifications within the HIV-1 envelope glycoprotein which restrict virus assembly and CD4-dependent infection. AIDS Res. Hum. Retrovir. 7:1991;501-510.
80. Hansen J. E., Clausen H., Nielsen C., Teglbjaerg L. S., Hansen L. L., Nielsen C. M., Dabelsteen E., Mathiesen L., Hakomori S. I., Nielsen J. O. Inhibition of human immunodeficiency virus (HIV) infectionin vitro. J. Virol. 64:1990;2833-2840.
81. Hansen J. E., Nielsen C., Arendrup M., Olofsson S., Mathiesen L., Nielsen J. O., Clausen H. Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus. J. Virol. 65:1991;6461-6467.
82. Hansen J. E., Clausen H., Hu S. L., Nielsen J. O., Olofsson S. An O-linked carbohydrate neutralization epitope of HIV-1 gp120 is expressed by HIV-1env. Arch. Virol. 126:1992;11-20.
83. Hasegawa A., Tsujimoto H., Maki N., Ishikawa K., Miura T., Fukasawa M., Miki K., Hayami M. Genomic divergence of HIV-2 from Ghana. AIDS Res. Hum. Retrovir. 5:1989;593-604.
84. Hatrick K., Taylor W. R. Sequence conservation and correlation measures in protein structure prediction. Comput. Chem. 18:1994;245-249.
85. He J., Chen Y., Farzan M., Choe H., Ohagen A., Gartner S., Busciglio J., Yang X., Hofmann W., Newman W., Mackay C. R., Sodroski J., Gabuzda D. CCR3 and CCR5 are coreceptors for HIV-1 infection of microglia. Nature. 385:1997;645-649.
86. Helseth E., Olshevsky U., Gabuzda D., Ardman B., Haseltine W., Sodroski J. Changes in the transmembrane region of the human immunodeficiency virus type-1 gp41 envelope glycoprotein affect membrane fusion. J. Virol. 64:1990;6314-6318.
87. Helseth E., Olshevsky U., Furman C., Sodroski J. Human immunodeficiency virus type-1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein. J. Virol. 65:1991;2119-2123.
88. Henikoff S., Henikoff J. G. Performance evaluation of amino acid substitution matrices. Proteins: Struct. Funct. Genet. 17:1993;49-61.
89. Hernandez L. D., Hoffman L. R., Wolfsberg T. G., White J. M. Virus-cell and cell-cell fusion. Annu. Rev. Cell. Dev. Biol. 12:1996;627-661.
90. Hesselgesser J., Halks-Miller M., DelVecchio V., Peiper S. C., Hoxie J., Kolson D. L., Taub D., Horuk R. CD4-independent association between HIV-1 gp120 and CXCR-4: functional chemokine receptors are expressed in human neurons. Curr. Biol. 7:1997;112-121.
91. Hirsch V. M., Edmondson P., Murphey-Corb M., Arbeille B., Johnson P. R., Mullins J. I. SIV adaptation to human cells. Nature. 341:1989a;573-574.
92. Hirsch V. M., Olmsted R. A., Murphey-Corb M., Purcell R. H., Johnson P. R. An African primate lentivirus (SIVsm) closely related to HIV-2. Nature. 339:1989b;389-392.
93. Ho D. D., Kaplan J. C., Rackauskas I. E., Gurney M. E. Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. Science. 239:1988;1021-1023.
94. Horuk R. Molecular properties of the chemokine receptor family. Trends Pharmacol. Sci. 15:1994;159-165.
95. Hu H., Shioda T., Moriya C., Xin X., Hasan M. K., Miyake K., Shimada T., Nagai Y. Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface. J. Virol. 70:1996;7462-7470.
96. Huang X., Smith M. C., Berzofsky J. A., Barchi J. J. Structural comparison of a 15 residue peptide from the V3 loop of HIV-1 IIIB and an O-glycosylated analogue. FEBS Letters. 393:1996;280-286.
97. Huang Y., Paxton W. A., Wolinsky S. M., Neumann A. U., Zhang L., He T., Kang S., Ceradini D., Jin Z., Yazdanbakhsh K., Kunstman K., Erickson D., Dragon E., Landau N. R., Phair J., Ho D. D., Koup R. A. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1996;1240-1243.
98. Hynes N. A., Adger-Johnson D., Dapolito G., Hirsch V. M. Rapid screening for simian immunodeficiency virus variants using Single-Strand Conformation Polymorphism of PCR-amplified DNA fragments. AIDS Res. Hum. Retrovir. 9:1993;803-806.
99. Ivey-Hoyle M., Clark R. K., Rosenberg M. The NH2-terminal 31 amino acids of human immunodeficiency virus type-1 envelope protein gp120 contain a potential gp41 contact site. J. Virol. 65:1991a;2682-2685.
100. Ivey-Hoyle M., Culp J. S., Chaikin M. A., Hellmig B. D., Matthews T. J., Sweet R. W., Rosenberg M. Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4. Proc. Natl Acad. Sci. USA. 88:1991b;512-516.
101. Iwai S., Pritchard C., Mann D. A., Karn J., Gait M. J. Recognition of the high affinity binding site in rev-response element RNA by the human immunodeficiency virus type 1 rev protein. Nucl. Acids Res. 20:1992;6465-6472.
102. Javaherian K., Langlois A. J., McDanal K. L., Ross L. I., Eckler C. L., Jellis A. T., Profy J. R., Rusche J. R., Bolognesi S. D., Putney S. D., Matthews T. J. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl Acad. Sci. USA. 86:1989;6768-6772.
103. Karry S., Zouali M. Identification of the B cell superantigen-binding site of HIV-1 gp120. Proc. Natl Acad. Sci. USA. 94:1997;1356-1360.
104. Keller R., Peden K., Paulous S., Montagnier L., Cordonnier A. Amino acid changes in the fourth conserved region of human immunodeficiency virus type 2 strain HIV-2ROD envelope glycoprotein modulate fusion. J. Virol. 67:1993;6253-6258.
105. Kennedy R. C., Henkel R. D., Pauletti D., Allan J. S., Lee T. H., Essex M., Dreesman G. R. Antiserum to a synthetic peptide recognises the HTLV-III envelope glycoprotein. Science. 231:1986;1556-1559.
106. Kestler H. W., Li Y., Naidu Y. M., Butler C. V., Ochs M. F., Jaenel G., King N. W., Daniel M. D., Desrosiers R. C. Comparison of simian immunodeficiency virus isolates. Nature. 331:1988;619-622.
107. Kestler H., Kodama T., Ringler D., Marthas M., Pedersen N., Lackner A., Refier D., Sehgal P., Daniel M., King N., Desrosiers R. Induction of AIDS in Rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science. 248:1990;1109-1112.
108. Kinsey N. E., Anderson M. G., Unangst T. J., Joag S. V., Narayan O., Zink M. C., Clements J. E. Antigenic variation of SIV: mutations in V4 alter the neutralization profile. Virology. 221:1996;14-21.
109. Kirchhoff F., Mori K., Desrosiers R. C. The V3 domain is a determinant of simian immunodeficiency virus-cell tropism. J. Virol. 68:1994a;3682-3692.
110. Kirchhoff F., Morrison H. G., Murray M. G., Rennert P., Desrosiers R. C. SIVmac expressing hybrid envelope proteins containing HIV-1 V3 and/or C4 sequences is not competent for replication. AIDS Res. Hum. Retrovir. 10:1994b;309-313.
111. Kliger Y., Shai Y. A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers. Biochemistry. 36:1997;5157-5169.
112. Kodama T., Wooley D. P., Naidu Y. M., Kestler H. W., Daniel M. D., Li Y., Desrosiers R. C. Significance of premature stop codons inenv. J. Virol. 63:1989;4709-4714.
113. Koito A., Stamatatos L., Cheng Mayer C. Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type 1 envelope gp120. Virology. 206:1995;878-884.
114. Korber B. T. M., MacInnes K., Smith R. F., Myers G. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J. Virol. 68:1994;6730-6744.
115. Kuhnel H., von Briesen H., Dietrich U., Adamski M., Mix D., Biesert L., Kreutz R., Immelmann A., Henco K., Meichsner C., Andreesen R., Gelderblom H., Rubsamen-Waigmann H. Molecular cloning of 2 West-African human immunodeficiency virus type-2 isolates that replicate well in macrophages: a Gambian isolate, from a patient with neurologic acquired immunodeficiency syndrome, and a highly divergent Ghanaian isolate. Proc. Natl Acad. Sci. USA. 86:1989;2383-2387.
116. Kumar P., Hui H. X., Kappes J. C., Haggarty B. S., Hoxie J. A., Arya S. K., Shaw G. M., Hahn B. H. Molecular characterization of an attenuated human immunodeficiency virus type-2 isolate. J. Virol. 64:1990;890-901.
117. Kunanusont C., Foy H. M., Kreiss J. K., Rerks-Ngarm S., Phanuphak P., Raktham S., Pau S., Young N. L. HIV-1 subtypes and male-to-female transmission in Thailand. Lancet. 345:1995;1078-1083.
118. LaBranche C. C., Sauter M. M., Haggarty B. S., Vance P. J., Romano J., Hart T. K., Bugelski P. J., Marsh M., Hoxie J. A. A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells. J. Virol. 69:1995;5217-5227.
119. Lamers S. L., Sleasman J. W., Goodenow M. M. A model for alignment ofenv. AIDS Res. Hum. Retrovir. 12:1996;1169-1178.
120. Lee W.-R., Syu W.-J., Du B., Matsuda M., Tan S., Wolf A., Essex M., Lee T.-H. Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA. 89:1992;2213-2217.
121. Lemasson I., Housset V., Calas B., Devaux C. Antigenic analysis of HIV type-1 external envelope (envenv. AIDS Res. Hum. Retrovir. 11:1995;1177-1186.
122. Leonard C. K., Spellman M. W., Riddle L., Harris R. J., Thomas J. N., Gregory T. J. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265:1990;10373-10382.
123. Levitt M. A simplified representation of protein conformations for rapid simulation of protein folding. J. Mol. Biol. 104:1976;59-107.
124. Li Y., Luo L., Thomas D. Y., Kang C. Y. Control of expression, glycosylation, and secretion of HIV-1 gp120 by homologous and heterologous signal sequences. Virology. 204:1994;266-278.
125. Liu R., Paxton W. A., Choe S., Ceradini D., Martin S. R., Horuk R., MacDonald M. E., Stuhlmann H., Koup R. A., Landau N. R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
126. Lodge R., Lalonde J.-P., Lemay G., Cohen E. A. The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells. EMBO J. 16:1997;695-705.
127. Louwagie J., Janssens W., Macsola J., Heyndrickx L., Hegerich P., van der Groen G., McCutchan F. E., Burke D. S. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J. Virol. 69:1995;263-271.
128. Lu M., Blacklow S. C., Kim P. S. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2:1995;1075-1082.
129. Luciw P. A., Shaw K. E. S., Unger R. E., Planelles V., Stout M. W., Lackner J. E., Prattlowe E., Leung N. J., Banapour B., Marthas M. L. Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). AIDS Res. Hum. Retrovir. 8:1992;395-402.
130. Marcon L., Choe H., Martin K. A., Farzan M., Ponath P. D., Wu L., Newman M., Gerard N., Gerard C., Sodroski J. Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. J. Virol. 71:1997;2522-2527.
131. Marlink R. Lesson from the second AIDS virus, HIV-2. AIDS. 10:1996;689-699.
132. Marlink R., Kanki P., Thior I., Travers K., Eisen G., Siby T., Traore I., Hsieh C. C., Dia M. C., Gueye E., Hellinger J., Gueyendiaye A., Sankale J. L., Ndoye I., Mboup S., Essex M. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science. 265:1994;1587-1590.
133. Mascola J. R., Louwagie J., McCutchan F. E., Fischer C. L., Hegerich P. A., Wagner K. F., Fowler A. K., McNeil J. G., Burke D. S. Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J. Infect. Dis. 169:1994;48-54.
134. McCutchan F. E., Hegerich P. A., Brennan T. P., Phanuphak P., Singharaj P., Jugsudee A., Berman P. W., Gray A. M., Fowler A. K., Burke D. S. Genetic variants of HIV-1 in Thailand. AIDS Res. Hum. Retrovir. 8:1992;1887-1895.
135. McCutchan F. E., Artenstein A. W., Sandersbuell E., Salminen M. O., Carr J. K., Mascola J. R., Yu X. F., Nelson K. E., Khamboonruang C., Schmitt D., Kieny M. P., McNeil J. G., Burke D. S. Diversity of the envelope glycoprotein among human immunodeficiency virus type-1 isolates of clade-E from Asia and Africa. J. Virol. 70:1996;3331-3338.
136. McKeating J. A., Balfe P. Human immunodeficiency virus envelope: structure and function. Aloia R. C., Curtain C. C. Membrane Interactions of Human Immunodeficiency Virus: Implications for Pathogenesis and Therapy in AIDS. 1992;Wiley-Liss Inc. New York.
137. McKeating J. A., Moore J. P., Ferguson M., Marsden H. S., Graham S., Almond J. W., Evans D. J., Weiss R. A. Monoclonal antibodies to the C4 region of human immunodeficiency virus type-1 gp120: use in topological analysis of a CD4 binding-site. AIDS Res. Hum. Retrovir. 8:1992;451-459.
138. McKnight A., Wilkinson D., Simmons G., Talbot S., Picard L., Ahuja M., Marsh M., Hoxie J. A., Clapham P. R. Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR-4) is both cell type and virus strain dependent. J. Virol. 71:1997;1692-1696.
139. Meyer B. E., Meinkoth J. L., Malim M. H. Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus rev proteins: identification of a family of transferable nuclear export signals. J. Virol. 70:1996;2350-2359.
140. Mizuochi T., Matthews T. J., Kato M., Hamako J., Titani K., Solomon J., Feizi T. Diversity of oligosaccharide structures on the envelope glycoprotein gp120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9: presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues. J. Biol. Chem. 265:1990;8519-8524.
141. Modrow S., Hahn B. H., Shaw G. M., Gallo R. C., Wong-Staal F., Wolf H. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J. Virol. 61:1987;570-578.
142. Montefiori D. C., Stewart K., Ahearn J. M., Zhou J. Complement mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21). J. Virol. 67:1993;2699-2706.
143. Moore J. P., Sodroski J. Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. J. Virol. 70:1996;1863-1872.
144. Moore J., Trkola A. HIV type 1 coreceptors, neutralization serotypes and vaccine development. AIDS Res. Hum. Retrovir. 13:1997;733-736.
145. Moore J. P., Thali M., Jameson B. A., Vignaux F., Lewis G. K., Poon S. W., MacArthur C., Fung M. S., Sun B., Durda P. J., Akerblom L., Wahren B., Ho D. D., Sattentau Q. J., Sodroski J. Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop. J. Virol. 67:1993;4785-4796.
146. Moore J. P., Sattentau Q. J., Wyatt R., Sodroski J. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J. Virol. 68:1994;469-484.
147. Morikawa Y., Moore J. P., Wilkinson A. J., Jones I. M. Reduction in CD4 binding affinity associated with removal of a single glycosylation site in the external glycoprotein of HIV-2. Virology. 180:1991;853-856.
148. Morrison H. G., Kirchhoff F., Desrosiers R. C. Effects of mutations in constant region-3 and region-4 of envelope of simian immunodeficiency virus. Virology. 210:1995;448-455.
149. Mulder-Kampinga G. A., Simonon A., Kuiken C. L., Dekkerm J., Scherpbier H. J., van de Perre P., Boer K., Goudsmit J. Similarity inenvgag. J. Virol. 69:1995;2285-2296.
150. Mulligan M. J., Yamshchikov G. V., Ritter G. D., Gao F., Jin M. J., Nail C. D., Spies C. P., Hahn B. H., Compans R. W. Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J. Virol. 66:1992;3971-3975.
151. Myers G., Lenroot R. HIV glycosylation: what does it portend? AIDS Res. Hum. Retrovir. 8:1992;1459-1460.
152. Myers G., MacInnes K., Korber B. The emergence of simian/human immunodeficiency viruses. AIDS Res. Hum. Retrovir. 8:1992;373-386.
153. Myers G., Korber B., Hahn B. H., Jeang K. T., Mellors J. W., McCutchan F. E., Henderson L. E., Pavlakis G. N. Editors of. 1995;Los Alamos National Laboratory, Los Alamos.
154. Novembre F. J., Hirsch V. M., McClure H. M., Fultz P. N., Johnson P. R. SIV from stump-tailed macaques: molecular characterization of a highly transmissible primate lentivirus. Virology. 186:1992;783-787.
155. O'Brien T. R., Winkler C., Dean M., Nelson J. A. E., Carrington M., Michael N. L., White G. C. HIV-1 infection in a man homozygous for CCR5Δ32. Lancet. 349:1997;1219.
156. Olsen G. J., Matsuda H., Hagstrom R., Overbeek R. fastDNAml, a tool for construction of phylogenetic trees of DNA sequences using maximum likelihood. CABIOS. 10:1994;41-48.
157. Oram J. D., Downing R. G., Roff M., Clegg J. C. S., Serwadda D., Carswell J. W. Nucleotide sequence of a Ugandan HIV-1 provirus reveals genetic diversity from other HIV-1 isolates. AIDS Res. Hum. Retrovir. 6:1990;1073-1078.
158. Orloff G. M., Kalish M. L., Chiphangwi J., Potts K. E., Ou C. Y., Schochetman G., Dallabetta G., Saah A. I., Miotti P. G. V3 loops of HIV-1 specimens from pregnant women in Malawi uniformly lack a potential N-linked glycosylation site. AIDS Res. Hum. Retrovir. 9:1993;705-706.
159. Ott M., Emiliani S., Van Lint C., Herbein G., Lovett J., Chirmule N., McCloskey T., Pahwa S., Verdin E. Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science. 275:1997;1481-1485.
160. Overbaugh J., Rudensey L. M. Alterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques. J. Virol. 66:1992;5937-5948.
161. Palker T. J., Matthews T. J., Clark M. E., Cianciolo G. J., Randall R. R., Langlois A. J., White G. C., Safai B., Snyderman R., Bolognesi D. P., Barton F. H. A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. Proc. Natl Acad. Sci. USA. 84:1987;2479-2483.
162. Palmer C., Balfe P., Fox D., May J. C., Frederiksson R., Fenyo E. M., McKeating J. A. Functional-characterization of the V1V2 region of human immunodeficiency virus type-1. Virology. 220:1996;436-449.
163. Papandreou M. J., Idziorek T., Miquelis R., Fenouillet E. Glycosylation and stability of mature HIV envelope glycoprotein conformation under various conditions. FEBS Letters. 379:1996;171-176.
164. Penny M. A., Thomas S. J., Douglas N. W., Ranjbar S., Holmes H., Daniels R. S. Env. AIDS Res. Hum. Retrovir. 12:1996;741-747.
165. +. J. Virol. 71:1997;3259-3262.
166. Pollard S. R., Rosa M. D., Rosa J. J., Wiley D. C. Truncated variants of gp120 bind CD4 with high-affinity and suggest a minimum CD4 binding region. EMBO J. 11:1992;585-591.
167. Poumbourios P., El Ahmar W., McPhee D. A., Kemp B. E. Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. J. Virol. 69:1995;1209-1218.
168. Poumbourios P., Wilson K. A., Center R. J., El Ahmar W., Kemp B. E. Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic α-helical/leucine zipper-like sequence. J. Virol. 71:1997;2041-2049.
169. Purtscher M., Trkola A., Grassauer A., Schulz P. M., Klima A., Dopper S., Gruber G., Buchacher A., Muster T., Katinger H. Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5. AIDS. 10:1996;587-593.
170. Rabenstein M., Shin Y. K. A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation. Biochemistry. 34:1995;13390-13397.
171. Ratner L., Haseltine W., Patarca R., Livak K. J., Starcich B., Josephs S. F., Doran E. R., Rafalski J. A., Whitehorn E. A., Baumeister K., Ivanoff L., Petteway S. R., Pearson M. L., Lautenberger J. A., Papas T. S., Ghrayeb J., Chang N. T., Gallo R. C., Wong-Staal F. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature. 313:1985;277-284.
172. Reeves J. D., Schulz T. F. The CD4-independent tropism of human immunodeficiency virus type 2 involves several regions of the envelope protein and correlates with a reduced activation threshold for envelope-mediated fusion. J. Virol. 71:1997;1453-1465.
173. Reeves J. D., McKnight A., Potempa S., Simmons G., Gray P. W., Power C. A., Wells T., Weiss R. A., Talbot S. J. CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3 and V28 for entry. Virology. 231:1997;130-134.
174. Rey-Cuille M. A., Galabru J., Laurent-Crawford A., Krust B., Montagnier L., Hovanessian A. G. HIV-2 EHO isolate has a divergent envelope gene and induces single cell killing by apoptosis. Virology. 202:1994;471-476.
175. Robertson D. L., Hahn B. H., Sharp P. M. Recombination in AIDS viruses. J. Mol. Evol. 40:1995;249-259.
176. Robey F. A., Harriskelson T., Robert-Guroff M., Batinic D., Ivanov B., Lewis M. S., Roller P. P. A synthetic conformational epitope from the C4 domain of HIV gp120 that binds CD4. J. Biol. Chem. 271:1996;17990-17995.
177. Rud E. W., Cranage M., Yon J., Quirk J., Ogilvie L., Cook N., Webster S., Dennis M., Clarke B. E. Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J. Gen. Virol. 75:1994;529-543.
178. Salminen M. O., Carr J. K., Burke D. S., McCutchan F. E. Identification of breakpoints in intergenotypic recombinants of HIV type-1 by bootscanning. AIDS Res. Hum. Retrovir. 11:1995;1423-1425.
179. Samson M., Libert F., Doranz B. J., Rucker J., Liesnard C., Farber C. M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R. J., Collman R. G., Doms R. W., Vassart G., Parmentier M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature. 382:1996;722-725.
180. Sattentau Q. J., Moore J. P. The role of CD4 in HIV binding and entry. Phil. Trans. Roy. Soc. ser. B. 342:1993;59-66.
181. Schonning K., Jansson B., Olofsson S., Hansen J. E. Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1. J. Gen. Virol. 77:1996;753-758.
182. Schulz T. F., Jameson B. A., Lopalco L., Siccardi A. G., Weiss R. A., Moore J. P. Conserved structural features in the interaction between retroviral surface and transmembrane glycoproteins. AIDS Res. Hum. Retrovir. 8:1992;1571-1580.
183. Shilatifard A., Merkle R. K., Helland D. E., Welles J. L., Haseltine W. A., Cummings R. D. Complex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamine. J. Virol. 67:1993;943-952.
184. Shimizu H., Hasebe F., Tsuchie H., Morikawa S., Ushijima H., Kitamura T. Analysis of a human immunodeficiency virus type 1 isolate carrying a truncated transmembrane glycoprotein. Virology. 189:1992;534-546.
185. Shotton C., Arnold C., Sattentau Q., Sodroski J., McKeating J. A. Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type-1 envelope glycoprotein. J. Virol. 69:1995;222-230.
186. Shugars D. C., Wild C. T., Greenwell T. K., Matthews T. J. Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 70:1996;2982-2991.
187. Siepel A. C., Halpern A. L., Macken C., Korber B. T. M. A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences. AIDS Res. Hum. Retrovir. 11:1995;1413-1416.
188. Simmonds P., Balfe P., Ludlam C. A., Bishop J. O., Leigh-Brown A. J. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J. Virol. 64:1990;5840-5850.
189. Simmons G., Wilkinson D., Reeves J. D., Dittmar M. T., Beddows S., Weber J., Carnegie G., Desselberger U., Gray P. W., Weiss R. A., Clapham P. R. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70:1996;8355-8360.
190. Simmons G., Clapham P. R., Picard L., Offord R. E., Rosenkilde M. M., Schwartz T. W., Buser R., Wells T. N. C., Proudfoot A. E. I. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science. 276:1997;276-279.
191. Sjolander S., Bolmstedt A., Akerblom L., Horal P., Olofsson S., Morein B., Sjolander A. N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for thein vivo. Virology. 215:1996;124-133.
192. Soto-Ramirez L. E., Renjifo B., McLane M. F., Marlink R., O'Hara C., Sutthent R., Wasi C., Vithayasai P., Vitheayasai V., Apichartpiyakul C., Auewarakul P., Cruz V. P., Chui D., Osathanondh R., Mayer K., Lee T., Essex M. HIV-1 Langerhans' cell tropism association with heterosexual transmission of HIV. Science. 271:1996;1291-1293.
193. Spire B., Sire J., Zachar V., Rey F., Barresinoussi F., Galibert F., Hampe A., Chermann J. C. Nucleotide sequence of HIV-1NDK: a highly cytopathic strain of the human immunodeficiency virus. Gene. 81:1989;275-284.
194. Srinivas S. K., Srinivas R. V., Anantharamaiah G. M., Segrest J. P., Compans R. W. Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. J. Biol. Chem. 267:1992;7121-7127.
195. Srinivasan A., Anand R., York D., Ranganathan P., Feorino P., Schochetman G., Curran J., Kalyanaraman V. S., Luciw P. A., Sanchez-Pescador R. Molecular characterization of human immunodeficiency virus from Zaire: nucleotide sequence analysis identifies conserved and variable domains in the envelope gene. Gene. 52:1987;71-82.
196. Stamatatos L., Cheng-Mayer C. Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range and syncytium-forming ability. J. Virol. 67:1993;5635-5639.
197. Stamatos N. M., Gomatos P. J., Cox J., Fowler A., Dow N., Wohlhieter J. A., Cross A. S. Desialylation of peripheral blood mononuclear cells promotes growth of HIV-1. Virology. 228:1997;123-131.
198. Starcich B. R., Hahn B. H., Shaw G. M., McNeely P. D., Modrow S., Wolf H., Parks E. S., Parks W. P., Josephs S. F., Gallo R. C., Wong-Staal F. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/ LAV, the retrovirus of AIDS. Cell. 45:1986;637-648.
199. Steffy K. R., Kraus G., Looney D. J., Wong-Staal F. Role of the fusogenic peptide sequence in syncytium induction and infectivity of human immunodeficiency virus type 2. J. Virol. 66:1992;4532-4535.
200. Strimmer K., von Haeseler A. Quartet Puzzling: a quartet maximum-likelihood method for reconstructing tree topologies. Mol. Biol. Evol. 13:1996;964-969.
201. Sullivan N., Thali M., Furman C., Ho D. D., Sodroski J. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type-1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody. J. Virol. 67:1993;3674-3679.
202. Taylor W. R. A flexible method to align large numbers of biological sequences. J. Mol. Evol. 28:1989;161-169.
203. Theodorou I., Meyer L., Magierowska M., Katlama C., Rouzioux C. HIV-1 infection in an individual homozygous for CCR5Δ32. Lancet. 349:1997;1219-1220.
204. Tong-Starksen S. E., Baur A., Lu X. B., Peck E., Peterlin B. M. Second exon of Tat of HIV-2 is required for optimaltrans. Virology. 195:1993;826-830.
205. Torres J. V., Malley A., Banapour B., Anderson D. E., Axthelm M. K., Gerdner M. B., Benjamini E. An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation. AIDS Res. Hum. Retrovir. 9:1993;423-430.
206. Trkola A., Purtscher M., Muster T., Ballaun C., Buchacher A., Sullivan N., Srinivasan K., Sodroski J., Moore J. P., Katinger H. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70:1996;1100-1108.
207. Vella C., Smith M. H., Farrar G. H., Jones D. H., Daniels R. S. A molecular and serologic study of the envelope gene of the British isolate, HIV-1 GB8. Vaccine. 13:1995;735-741.
208. Venable R. M., Pastor R. R., Brooks B. R., Carson F. W. Theoretically determined three-dimensional structures for amphipathic segments of the HIV-1 gp41 envelope glycoprotein. AIDS Res. Hum. Retrovir. 5:1989;7-22.
209. Wang W. K., Essex M., Lee T. H. The highly conserved aspartic acid residue between hypervariable regions 1 and 2 of human immunodeficiency virus type 1 gp120 is important for early stages of virus replication. J. Virol. 69:1995;538-542.
210. Warrier S. V., Pinter A., Honnen W. J., Girard M., Muchmore E., Tilley S. A. A novel, glycan-dependent epitope in the V2 domain of human immunodeficiency virus type-1 rgp120 is recognized by a highly potent, neutralizing chimpanzee monoclonal-antibody. J. Virol. 68:1994;4636-4642.
211. Weissenhorn W., Wharton S. A., Calder L. J., Earl P. L., Moss B., Aliprandis E., Skehel J. J., Wiley D. C. The ectodomain of HIV-1env. EMBO J. 15:1996;1507-1514.
212. Weissenhorn W., Dessen A., Harrison S. C., Skehel J. J., Wiley D. C. Atomic structure of the ectodomain from HIV-1 gp41. Nature. 387:1997;426-430.
213. Wells T. N. C., Proudfoot A. E. I., Power C. A., Marsh M. Chemokine receptors: the new frontier for AIDS research. Chem. Biol. 3:1996;603-609.
214. Westervelt P., Trowbridge D. B., Epstein L. G., Blumberg B. M., Li Y., Hahn B. H., Shaw G. M., Price R. W., Ratner L. Macrophage tropism determinants of human immunodeficiency virus type 1in vivo. J. Virol. 66:1992;2577-2582.
215. Wild C., Dubay J. W., Greenwell T., Baird T., Oas T. G., McDanal C., Hunter E., Matthews T. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl Acad. Sci. USA. 91:1994;12676-12680.
216. Willey R. L., Martin M. A. Association of human immunodeficiency virus type-1 envelope glycoprotein with particles depends on interactions between the third variable and conserved regions of gp120. J. Virol. 67:1993;3639-3643.
217. Willey R. L., Smith D. H., Laskey L. A., Theodore T. S., Earl P. L., Moss B., Capon D. J., Martin M. A. In vitro. J. Virol. 62:1988;139-147.
218. Willey R. L., Theodore T. S., Martin M. A. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope. J. Virol. 68:1994;4409-4419.
219. Willey R. L., Shibata R., Freed E. O., Cho M. W., Martin M. A. Differential glycosylation, virion incorporation and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures. J. Virol. 70:1996;6431-6436.
220. Wolinsky S. M., Wike C. M., Korber B. T., Hutto C., Parks W. P., Rosenblum L. L., Kuntsman K. J., Furtado M. R., Munoz J. L. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science. 255:1992;1134-1137.
221. Wu L., Gerard N. P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A. A., Desjardin E., Newman W., Gerard C., Sodroski J. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR5. Nature. 384:1996;179-183.
222. Wu L., Paxton W. A., Kassam N., Ruffing N., Rottman J. B., Sullivan N., Choe H., Sodroski J., Newman W., Koup R. A., Mackay C. R. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1,in vitro. J. Exp. Med. 185:1997;1681-1691.
223. Wu Z., Kayman S. C., Honnen W., Revesz K., Chen H., Vijhwarrier S., Tilley S. A., Mckeating J., Shotton C., Pinter A. Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type-1 gp120: role of glycosylation in the correct folding of the V1/V2 domain. J. Virol. 69:1995;2271-2278.
224. Wu Z. G., Qian G., Zhen Q. L., Narayan O., Stephens E. B. Neutralization of SIV (mac)239/17e in lymphocyte cultures involves virus strain-specific linear and conformational epitopes encoded by different regions of theenv. Virology. 222:1996;184-192.
225. Wyatt R., Thali M., Tilley S., Pinter A., Posner M., Ho D., Robinson J., Sodroski J. Relationship of the human immunodeficiency virus type-1 gp120 third variable loop to a component of the CD4 binding-site in the fourth conserved region. J. Virol. 66:1992;6997-7004.
226. Wyatt R., Sullivan N., Thali M., Repke H., Ho D., Robinson J., Posner M., Sodroski J. Functional and immunological characterization of human immunodeficiency virus type-1 envelope glycoproteins containing deletions of the major variable regions. J. Virol. 67:1993;4557-4565.
227. Yang C. L., Spies C. P., Compans R. W. The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated. Proc. Natl Acad. Sci. USA. 92:1995;9871-9875.
228. Yourno J., Josephs S. F., Reitz M., Zagury D., Wong-Staal F., Gallo R. C. Nucleotide sequence analysis of theenv. AIDS Res. Hum. Retrovir. 4:1988;165-173.
229. Yu X.-F., Wang Z., Beyrer C., Celentano D. D., Khamboonruang C., Allen E., Nelson K. Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in Northern Thailand. J. Virol. 69:1995;4649-4655.
230. Yuan T., Mietzner T. A., Montelaro R. C., Vogel H. J. Characterization of the calmodulin binding domain of SIV transmembrane glycoprotein by NMR and CD spectroscopy. Biochemistry. 34:1995;10690-10696.
231. Zhang L. Q., MacKenzie P., Cleland A., Holmes E. C., Leigh-Brown A. J., Simmonds P. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J. Virol. 67:1993;3345-3356.
232. Zhong P., Peeters M., Janssens W., Fransen K., Heyndrickx L., Vanham G., Willems B., Piot P., van der Groen G. Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D. AIDS Res. Hum. Retrovir. 11:1995;239-248.
233. Zhu T., Mo H., Wang N., Nam D. S., Cao Y., Koup R. A., Ho D. D. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science. 261:1993;1179-1181.
234. Zhu T. F., Wang N., Carr A., Nam D. S., Moor-Jankowski R., Cooper D. A., Ho D. D. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J. Virol. 70:1996;3098-3107.